Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biopol ChemicalsNSE:BIOPOL +0.31%20 EBITDA Margin % is 18.51% as of Mar. 2026, which is 10% above its 10-year median of 16.86. GuruFocus rates NSE:BIOPOL with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 1,578 Chemicals companies, Biopol Chemicals ranks better than 77.95% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Biopol Chemicals's EBITDA for the
six
months ended in Mar. 2026 was ₹91.6 Mil. Biopol Chemicals's Revenue for the
six
months ended in Mar. 2026 was ₹494.9 Mil. Therefore, Biopol Chemicals's EBITDA margin for the quarter that ended in Mar. 2026 was 18.51%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Biopol Chemicals EBITDA Margin % Related Terms
Biopol Chemicals EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Biopol Chemicals's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biopol Chemicals EBITDA Margin % Chart
Biopol Chemicals Annual Data
Trend
Mar24
Mar25
Mar26
EBITDA Margin %
16.87
13.16
16.86
Biopol Chemicals Semi-Annual Data
Mar24
Mar25
Mar26
EBITDA Margin %
0.00
13.15
18.51
NSE:BIOPOL vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Biopol Chemicals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biopol Chemicals EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Biopol Chemicals's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Biopol Chemicals's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biopol Chemicals (NSE:BIOPOL) has a EBITDA Margin % of 18.51% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Biopol Chemicals and its competitors. This is 10% above median its historical median of 16.86. Over the past decade, Biopol Chemicals' EBITDA Margin % has ranged from 13.16 to 18.51. According to the industry distribution chart, Biopol Chemicals ranks #348 out of 1578 companies in the Chemicals industry, placing it in the top 22.1%.
Is Biopol Chemicals' EBITDA Margin % too high?
Biopol Chemicals' current EBITDA Margin % of 18.51% is 10% above median its 10-year median of 16.86. Over the past 10 years, this metric has ranged from a low of 13.16 to a high of 18.51. The Chemicals industry median EBITDA Margin % is 9.64. Biopol Chemicals' value of 18.51% is 92% above this industry median. Based on the distribution chart, Biopol Chemicals ranks #348 out of 1578 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Biopol Chemicals has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Biopol Chemicals' EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Biopol Chemicals ranks #348 out of 1578 companies for EBITDA Margin %. This places Biopol Chemicals in the top 22% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. Biopol Chemicals' value of 18.51% is 92% above this benchmark. Historically, Biopol Chemicals' own EBITDA Margin % has ranged from 13.16 to 18.51 over the past decade. While the company's 10-year median is 16.86 vs. the industry median of 9.64, Biopol Chemicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biopol Chemicals's current EBITDA Margin % of 18.51% is 92% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Biopol Chemicals and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biopol Chemicals's current EBITDA Margin % is 18.51%, which is 10% above median its own 10-year median of 16.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biopol Chemicals stock overvalued right now?
Biopol Chemicals (NSE:BIOPOL) has a current EBITDA Margin % of 18.51%. The current EBITDA Margin % is 18.51%, which is 10% above median its 10-year median of 16.86 and 92% above the Chemicals industry median of 9.64. Biopol Chemicals' overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Biopol Chemicals (NSE:BIOPOL), the current EBITDA Margin % is 18.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AddressStreet No 372 Action Area 1, Unit No 2ES3B1, 2nd Floor Mani Casadona, IIF Newtown Alia University, North 24 Parganas, Chakpachuria, New town, WB, IND, 700160
Biopol Chemicals Ltd is engaged in the business of trading, manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Its product portfolio consists of silicone-based products, emulsifier-based products, biochemical products and polyelectrolyte products. It serves various industry segments, including softeners, emulsions and hardeners for textiles; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants in agriculture; and release agents in industrial chemicals. The majority of the company's revenue is derived from the sale of its products to customers in the textile sector.
20GF Score
Get the complete analysis for NSE:BIOPOL
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BIOPOL has been successfully added to your 
